Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Predictive Factors for the Efficacy of CD19 CAR-T Therapy in Relapsed/Refractory Large B-Cell Lymphoma: A Clinical StudyDisease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, large B-cell lymphomaRecruitingNot stated2025-11-19NCT07236203

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Fudan University653

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Fudan University Shanghai Cancer CenterShanghaiChina2